Template:Latest
From WikiMD's Food, Medicine & Wellness Encyclopedia
Medical Headlines
FDA approves New Weight Loss Injection[edit source]
On November 8th, 2023, the US FDA approves the hugely popular diabetes drug Mounjaro for weight loss under the brand name Zepbound. As one of the most popular injections for weight loss with stunning results, it has been used off label and now gets the official approval.
- Update: Zepbound is now available at retain pharmacies across the United States as of December 6th, 2023 and W8MD weight loss centers offers prescriptions for eligible patients. Learn more...
- Wezlana approved by the US FDA as a biosimilar to Stelara to treat many inflammatory conditions including Psoriatic arthritis, Crohn's disease and Ulcerative colitis. Learn more...
- New drug approval: On August 04, 2023, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults costing as much as $15,900.00 for a two week course of treatment.
